Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Nevro Corp (NY: NVRO )

8.420 +0.060 (+0.72%)
Official Closing Price Updated: 7:00 PM EDT, Jun 28, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,362,491
Open 8.420
Bid (Size) 7.000 (1)
Ask (Size) 9.980 (1)
Prev. Close 8.360
Today's Range 8.080 - 8.500
52wk Range 7.850 - 26.53
Shares Outstanding 35,817,154
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Assessing Nevro: Insights From 9 Financial Analysts
Via Benzinga
NVRO Stock Earnings: Nevro Beats EPS, Beats Revenue for Q1 2024
NVRO stock results show that Nevro beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace

Performance

YTD
-59.44%
-59.44%
1 Month
-8.97%
-8.97%
3 Month
-36.79%
-36.79%
6 Month
-60.87%
-60.87%
1 Year
-66.99%
-66.99%

More News

Read More
Non-Opioid Revolution: Beacons of Hope in Opioid Crisis and a $50 Million Spin-Off
Via AB Newswire
Where Nevro Stands With Analysts
Via Benzinga
Why Nevro Stock Lagged the Market on Thursday
Via The Motley Fool
Analyst Scoreboard: 4 Ratings For Nevro
Via Benzinga
Nevro: Q4 Earnings Insights
Via Benzinga
Earnings Scheduled For February 21, 2024
Via Benzinga
What Analysts Are Saying About Nevro Stock
Via Benzinga
Forecasting The Future: 6 Analyst Projections For Nevro
Via Benzinga
Where Nevro Stands With Analysts
Via Benzinga
What 4 Analyst Ratings Have To Say About Nevro
Via Benzinga
Earnings Preview For Nevro
Via Benzinga
What 21 Analyst Ratings Have To Say About Nevro
Via Benzinga
Expert Ratings for Nevro
Via Benzinga
Why Shares of Nevro Are Down Wednesday
Via The Motley Fool
Potential Turnaround Ahead for Nevro: Q2 Earnings, Guidance Lag Wall Street Estimates
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
What 17 Analyst Ratings Have To Say About Nevro
Via Benzinga
Uncertainties In Nevro's Core Business Lead To Revised FY24 Projections By Oppenheimer Analyst
Via Benzinga
Why Exact Sciences Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 19, 2023
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Why THOR Industries Shares Are Trading Higher By 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.